U.S. Markets open in 1 hr 54 mins

DexCom, Inc. (DXCM)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
77.75+0.42 (+0.54%)
At close: 4:00PM EDT
People also watch
  • The breakout has begun (2 weeks ago)....
  • Moved through the 50DMA like a BULL!
  • as I told everybody in this post look at my prior comments I said Apple will be using Dexcom sensors. Everybody freaking ignored me. now I will make another call and that is profit takers are taking their profits right now. Going to wait till this dips back to 70
  • New Player In Glucose Monitoring-NEW GLUCOSE WATCH. http://www.pkvitality.com/crowdfunding/

  • At the Apple Worldwide Developers Conference (WWDC) it was just announced their smart watches will be able to pull info from the Dexcom CGMs.
  • @SMD: How is that Apple "partnership" you were so excited about for their watch that no one wears? Is this the same type of partnership that they have with Google in which THEY PAY Google? You didn't know that did you? Have you ever heard of Roku? It is a TV device that enables to to better navigate your smart TV. My Roku has 4 "branded" buttons so that I can go straight to that service. They are Netflix, Amazon, Rdio, and Hulu. But when I push on the Rdio button nothing happens cause that company already went out of business. But at least they had a great partnership with Roku beforehand that they no doubt paid handsomely for. You are funny SMD. Remember me at $30.00.
  • Expect increased volume, could spur a breakout
  • For all you Dexcom lovers.... this has been going on for years..
    read and heed....

    DXCM - Dexcom Inc - SEC Form 4 Insider Trading Screener - OpenInsider
    Insider trades for Dexcom Inc (DXCM). Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Real-time Insider Trading Stock Screener. Long and Short Trading Ideas using Insider Transaction Data.
  • DXCM is up 4.91% to 71.00
  • Some info about competition - earnings call transcript:

    Regarding the U.S. launch of the MiniMed 670G, we have approximately 750 people taking part in our Customer Training Phase. The feedback has been extremely positive with a continued increase in patient satisfaction levels. We are preparing for a broader launch in June to the more than 20,000 pump users that are enrolled in our Priority Access Program. As stated before, we do not expect revenue growth to ramp substantially until after we have fulfilled the Priority Access orders, given the low revenue associated with the upgrade program.
  • https://twitter.com/atbwebb?ref_src=twsrc%5Egoogle%7Ctwcamp%5Enews%7Ctwgr%5Eauthor

    Alex Webb (@atbwebb) | Twitter
    The latest Tweets from Alex Webb (@atbwebb). Bloomberg @business @technology reporter in SF, via Germany and UK. If you discern an opinion, it's mine. Spam me at awebb25[at]bloomberg[dot]net. San Francisco, CA
  • A blast from the past...


    Sohn Conference Winner Short Dexcom (DXCM) Slides
    Sohn Conference Winner - DXCM is a medical device company that develops and manufactures conXnuous glucose monitoring (CGM) systems for
  • Tim Cook was using a Dexcom sensor with his watch.
  • PT

    5/22/17 PiperJaffray Reinstates Overweight with a $78.00 PT
  • Hope sees the invisible, feels the intangible,http://dataunion.tistory.com/10116

    DexCom NASDAQ $DXCM Correlation Histogram
    DXCM X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks Sep-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is 0.9 In other words, the correlation coefficient of the other
  • See why biotech/pharma shareholders are adding this breakthrough wound care to their portfolio. BioLargo recent 10Q states:
    • Advanced Wound Care products are ready, all studies successfully completed, and they expect to file a 510K with FDA in less than 90 days
    • Woundcare market is over $6 Billion with high growth rate
    • Tanya Rhodes, ex VP of Smith & Nephew Wound Care Product Development is leading the BLGO/Clyra Medical 510K filing
    • BLGO/Clyra Medical Wound Care Products promote healing substantially better than competing products, fight infection better than competing products, are effective against resistant microbials, and are low cost
    • Sales could commence late 2017
    • Sales and or licensing agreement/s could be very significant and fast
    • Company is now commercializing several other disruptive products in large markets



    Clyra Medical | Make Life Better
  • Apple Watch is coming out with glucose monitor wrist watch.
  • Uh Oh!!! Another down leg for DXCM on the way. These Apple headlines sure are not good for DXCM! Get out before this stock is back at $30. You will thank me later. Promise.

    Apple CEO Tim Cook test-drove a device that tracks his blood sugar, hinting at Apple's interest in the space
    Tim Cook has been test-driving a glucose monitor to understand how his blood sugar responds to factors like food and exercise
    CNBC reported last month that Apple has a team dedicated to the "holy grail" in diabetes: Non-invasive and continuous glucose monitoring
    Cook iterated in a discussion with university students in February that Apple is "really excited" about its potential in health care